selegiline has been researched along with Encephalopathy, Toxic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurlan, R | 1 |
Jyoti, A; Sethi, P; Sharma, D | 1 |
Ebadi, M; Muralikrishnan, D | 1 |
3 other study(ies) available for selegiline and Encephalopathy, Toxic
Article | Year |
---|---|
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome | 2005 |
Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain.
Topics: Aldehydes; Aluminum Chloride; Aluminum Compounds; Animals; Antioxidants; Bacopa; Cerebral Cortex; Chlorides; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Transferase; India; Lipid Peroxidation; Male; Medicine, Ayurvedic; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Plant Extracts; Protein Carbonylation; Rats; Rats, Wistar; Selegiline; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2007 |
SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antioxidants; Catalase; Dopamine Agents; Dopamine Agonists; Glutathione; Mice; Mice, Inbred BALB C; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Nerve Tissue Proteins; Neurotoxicity Syndromes; Selegiline; Superoxide Dismutase | 2001 |